Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis

{ 'indexed': {'date-parts': [[2024, 10, 5]], 'date-time': '2024-10-05T04:07:39Z', 'timestamp': 1728101259916}, 'reference-count': 49, 'publisher': 'Springer Science and Business Media LLC', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2024, 10, 4]], 'date-time': '2024-10-04T00:00:00Z', 'timestamp': 1728000000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc-nd/4.0'}, { 'start': { 'date-parts': [[2024, 10, 4]], 'date-time': '2024-10-04T00:00:00Z', 'timestamp': 1728000000000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc-nd/4.0'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'DOI': '10.1186/s40001-024-02062-5', 'type': 'journal-article', 'created': {'date-parts': [[2024, 10, 4]], 'date-time': '2024-10-04T07:02:08Z', 'timestamp': 1728025328000}, 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely ' 'vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis', 'prefix': '10.1186', 'volume': '29', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-0263-0703', 'authenticated-orcid': False, 'given': 'Mazzitelli', 'family': 'Maria', 'sequence': 'first', 'affiliation': []}, {'given': 'Alberto Enrico', 'family': 'Maraolo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claudia', 'family': 'Cozzolino', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lolita', 'family': 'Sasset', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna', 'family': 'Ferrari', 'sequence': 'additional', 'affiliation': []}, {'given': 'Monica', 'family': 'Basso', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eleonora', 'family': 'Vania', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicola', 'family': 'Bonadiman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vincenzo', 'family': 'Scaglione', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna Maria', 'family': 'Cattelan', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2024, 10, 4]]}, 'reference': [ { 'key': '2062_CR1', 'doi-asserted-by': 'publisher', 'first-page': '1397040', 'DOI': '10.3389/fimmu.2024.1397040', 'volume': '15', 'author': 'RR Razonable', 'year': '2024', 'unstructured': 'Razonable RR. Protecting the vulnerable: addressing the COVID-19 care ' 'needs of people with compromised immunity. Front Immunol. ' '2024;15:1397040. https://doi.org/10.3389/fimmu.2024.1397040.', 'journal-title': 'Front Immunol'}, { 'issue': '2', 'key': '2062_CR2', 'doi-asserted-by': 'publisher', 'first-page': '361', 'DOI': '10.1093/cid/ciad546', 'volume': '78', 'author': 'S Feys', 'year': '2024', 'unstructured': 'Feys S, Lagrou K, Lauwers HM, Haenen K, Jacobs C, Brusselmans M, et al. ' 'High burden of COVID-19-associated pulmonary aspergillosis in severely ' 'immunocompromised patients requiring mechanical ventilation. Clin Infect ' 'Dis. 2024;78(2):361–70. https://doi.org/10.1093/cid/ciad546.', 'journal-title': 'Clin Infect Dis'}, { 'issue': '10', 'key': '2062_CR3', 'doi-asserted-by': 'publisher', 'first-page': '1779', 'DOI': '10.1016/j.immuni.2022.09.006', 'volume': '55', 'author': 'S DeWolf', 'year': '2022', 'unstructured': 'DeWolf S, Laracy JC, Perales MA, Kamboj M, van den Brink MRM, Vardhana ' 'S. SARS-CoV-2 in immunocompromised individuals. Immunity. ' '2022;55(10):1779–98. https://doi.org/10.1016/j.immuni.2022.09.006.', 'journal-title': 'Immunity'}, { 'issue': '1', 'key': '2062_CR4', 'doi-asserted-by': 'publisher', 'first-page': '123', 'DOI': '10.1186/s40001-024-01718-6', 'volume': '29', 'author': 'A De Vito', 'year': '2024', 'unstructured': 'De Vito A, Saderi L, Colpani A, Puci MV, Zauli B, Fiore V, et al. New ' 'score to predict COVID-19 progression in vaccine and early treatment ' 'era: the COVID-19 Sardinian Progression Score (CSPS). Eur J Med Res. ' '2024;29(1):123. https://doi.org/10.1186/s40001-024-01718-6.', 'journal-title': 'Eur J Med Res'}, { 'key': '2062_CR5', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41579-024-01036-y', 'author': 'JF Chan', 'year': '2024', 'unstructured': 'Chan JF, Yuan S, Chu H, Sridhar S, Yuen KY. COVID-19 drug discovery and ' 'treatment options. Nat Rev Microbiol. 2024. ' 'https://doi.org/10.1038/s41579-024-01036-y.', 'journal-title': 'Nat Rev Microbiol'}, { 'key': '2062_CR6', 'doi-asserted-by': 'publisher', 'first-page': '639970', 'DOI': '10.3389/fmed.2021.639970', 'volume': '8', 'author': 'A Di Castelnuovo', 'year': '2021', 'unstructured': 'Di Castelnuovo A, Costanzo S, Antinori A, Berselli N, Blandi L, Bonaccio ' 'M, et al. Lopinavir/ritonavir and darunavir/cobicistat in hospitalized ' 'COVID-19 patients: findings from the multicenter Italian CORIST study. ' 'Front Med (Lausanne). 2021;8:639970. ' 'https://doi.org/10.3389/fmed.2021.639970.', 'journal-title': 'Front Med (Lausanne)'}, { 'issue': '11', 'key': '2062_CR7', 'doi-asserted-by': 'publisher', 'first-page': '2180', 'DOI': '10.3390/v15112180', 'volume': '15', 'author': 'A De Vito', 'year': '2023', 'unstructured': 'De Vito A, Moi G, Saderi L, Puci MV, Colpani A, Firino L, et al. ' 'Vaccination and antiviral treatment reduce the time to negative ' 'SARS-CoV-2 swab: a real-life study. Viruses. 2023;15(11):2180. ' 'https://doi.org/10.3390/v15112180.', 'journal-title': 'Viruses'}, { 'issue': '5', 'key': '2062_CR8', 'doi-asserted-by': 'publisher', 'first-page': '329', 'DOI': '10.2459/JCM.0000000000001160', 'volume': '22', 'author': 'C Spaccarotella', 'year': '2021', 'unstructured': 'Spaccarotella C, Mazzitelli M, Migliarino S, Curcio A, De Rosa S, Torti ' 'C, et al. Therapy with RAS inhibitors during the COVID-19 pandemic. J ' 'Cardiovasc Med (Hagerstown). 2021;22(5):329–34. ' 'https://doi.org/10.2459/JCM.0000000000001160.', 'journal-title': 'J Cardiovasc Med (Hagerstown)'}, { 'issue': '6', 'key': '2062_CR9', 'doi-asserted-by': 'publisher', 'first-page': '2749', 'DOI': '10.1007/s10238-023-01036-x', 'volume': '23', 'author': 'D Mengato', 'year': '2023', 'unstructured': 'Mengato D, Mazzitelli M, Francavilla A, Bettio M, Sasset L, Presa N, et ' 'al. Changing patterns and clinical outcomes of hospitalized patients ' 'with COVID-19 severe pneumonia treated with remdesivir according to ' 'vaccination status: results from a real-world retrospective study. Clin ' 'Exp Med. 2023;23(6):2749–56. https://doi.org/10.1007/s10238-023-01036-x.', 'journal-title': 'Clin Exp Med'}, { 'issue': '2', 'key': '2062_CR10', 'doi-asserted-by': 'publisher', 'first-page': '384', 'DOI': '10.3390/v15020384', 'volume': '15', 'author': 'M Mazzitelli', 'year': '2023', 'unstructured': 'Mazzitelli M, Mengato D, Sasset L, Ferrari A, Gardin S, Scaglione V, et ' 'al. Molnupiravir and nirmatrelvir/ritonavir: tolerability, safety, and ' 'adherence in a retrospective cohort study. Viruses. 2023;15(2):384. ' 'https://doi.org/10.3390/v15020384.', 'journal-title': 'Viruses'}, { 'issue': '4', 'key': '2062_CR11', 'doi-asserted-by': 'publisher', 'first-page': '209', 'DOI': '10.1007/s40472-022-00385-y', 'volume': '9', 'author': 'V Dioverti', 'year': '2022', 'unstructured': 'Dioverti V, Salto-Alejandre S, Haidar G. Immunocompromised patients with ' 'protracted COVID-19: a Review of “Long Persisters.” Curr Transplant Rep. ' '2022;9(4):209–18. https://doi.org/10.1007/s40472-022-00385-y.', 'journal-title': 'Curr Transplant Rep'}, { 'issue': '1', 'key': '2062_CR12', 'doi-asserted-by': 'publisher', 'first-page': '301', 'DOI': '10.1186/s12985-023-02269-8', 'volume': '20', 'author': 'I Gentile', 'year': '2023', 'unstructured': 'Gentile I, Foggia M, Silvitelli M, Sardanelli A, Cattaneo L, Viceconte ' 'G. Optimizing COVID-19 treatment in immunocompromised patients: early ' 'combination therapy with remdesivir, nirmatrelvir/ritonavir and ' 'sotrovimab. Virol J. 2023;20(1):301. ' 'https://doi.org/10.1186/s12985-023-02269-8.', 'journal-title': 'Virol J'}, { 'key': '2062_CR13', 'doi-asserted-by': 'publisher', 'first-page': 'e0011923', 'DOI': '10.1128/cmr.00119-23', 'volume': '2024', 'author': 'D Focosi', 'year': '2024', 'unstructured': 'Focosi D, Franchini M, Maggi F, Shoham S. COVID-19 therapeutics. Clin ' 'Microbiol Rev. 2024;2024:e0011923. https://doi.org/10.1128/cmr.00119-23.', 'journal-title': 'Clin Microbiol Rev'}, { 'key': '2062_CR14', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.lanepe.2023.100684', 'volume': '31', 'author': 'C Torti', 'year': '2023', 'unstructured': 'Torti C, Olimpieri PP, Bonfanti P, Tascini C, Celant S, Tacconi D, et ' 'al. Real-life comparison of mortality in patients with SARS-CoV-2 ' 'infection at risk for clinical progression treated with molnupiravir or ' 'nirmatrelvir plus ritonavir during the Omicron era in Italy: a ' 'nationwide, cohort study. Lancet Reg Health Eur. 2023;31: 100684. ' 'https://doi.org/10.1016/j.lanepe.2023.100684.', 'journal-title': 'Lancet Reg Health Eur'}, { 'issue': '5', 'key': '2062_CR15', 'doi-asserted-by': 'publisher', 'first-page': '672', 'DOI': '10.1021/acscentsci.0c00489', 'volume': '6', 'author': 'RT Eastman', 'year': '2020', 'unstructured': 'Eastman RT, Roth JS, Brimacombe KR, Simeonov A, Shen M, Patnaik S, et ' 'al. Remdesivir: a review of its discovery and development leading to ' 'emergency use authorization for treatment of COVID-19. ACS Cent Sci. ' '2020;6(5):672–83. https://doi.org/10.1021/acscentsci.0c00489.', 'journal-title': 'ACS Cent Sci'}, { 'issue': '1', 'key': '2062_CR16', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1007/s40121-023-00900-3', 'volume': '13', 'author': 'PO Godwin', 'year': '2024', 'unstructured': 'Godwin PO, Polsonetti B, Caron MF, Oppelt TF. Remdesivir for the ' 'treatment of COVID-19: a narrative review. Infect Dis Ther. ' '2024;13(1):1–19. https://doi.org/10.1007/s40121-023-00900-3.', 'journal-title': 'Infect Dis Ther'}, { 'issue': '12', 'key': '2062_CR17', 'doi-asserted-by': 'publisher', 'first-page': '1626', 'DOI': '10.1093/cid/ciad460', 'volume': '77', 'author': 'E Mozaffari', 'year': '2023', 'unstructured': 'Mozaffari E, Chandak A, Gottlieb RL, Chima-Melton C, Read SH, Jiang H, ' 'et al. Remdesivir reduced mortality in immunocompromised patients ' 'hospitalized for COVID-19 across variant waves: findings from routine ' 'clinical practice. Clin Infect Dis. 2023;77(12):1626–34. ' 'https://doi.org/10.1093/cid/ciad460.', 'journal-title': 'Clin Infect Dis'}, { 'issue': '3', 'key': '2062_CR18', 'doi-asserted-by': 'publisher', 'first-page': 'e28660', 'DOI': '10.1002/jmv.28660', 'volume': '95', 'author': 'M Mazzitelli', 'year': '2023', 'unstructured': 'Mazzitelli M, Trunfio M, Sasset L, Scaglione V, Ferrari A, Mengato D, et ' 'al. Risk of hospitalization and sequelae in patients with COVID-19 ' 'treated with 3-day early remdesivir vs. controls in the vaccine and ' 'Omicron era: a real-life cohort study. J Med Virol. 2023;95(3):e28660. ' 'https://doi.org/10.1002/jmv.28660.', 'journal-title': 'J Med Virol'}, { 'issue': '9', 'key': '2062_CR19', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.29082', 'volume': '95', 'author': 'JM Caso', 'year': '2023', 'unstructured': 'Caso JM, Fernandez-Ruiz M, Lopez-Medrano F, Caro-Teller JM, Lizasoain M, ' 'San-Juan R, et al. Nirmatrelvir/ritonavir for the treatment of ' 'immunocompromised adult patients with early-stage symptomatic COVID-19: ' 'a real-life experience. J Med Virol. 2023;95(9): e29082. ' 'https://doi.org/10.1002/jmv.29082.', 'journal-title': 'J Med Virol'}, { 'issue': '7', 'key': '2062_CR20', 'doi-asserted-by': 'publisher', 'first-page': '1515', 'DOI': '10.3390/v15071515', 'volume': '15', 'author': 'D Basoulis', 'year': '2023', 'unstructured': 'Basoulis D, Tsakanikas A, Gkoufa A, Bitsani A, Karamanakos G, ' 'Mastrogianni E, et al. Effectiveness of oral nirmatrelvir/ritonavir vs. ' 'intravenous three-day remdesivir in preventing progression to severe ' 'COVID-19: a single-center, prospective, comparative, real-life study. ' 'Viruses. 2023;15(7):1515. https://doi.org/10.3390/v15071515.', 'journal-title': 'Viruses'}, { 'issue': '7', 'key': '2062_CR21', 'doi-asserted-by': 'publisher', 'first-page': '1589', 'DOI': '10.1007/s40121-024-00994-3', 'volume': '13', 'author': 'F Bai', 'year': '2024', 'unstructured': 'Bai F, Beringheli T, Vitaletti V, Santoro A, Mola F, Copes A, et al. ' 'Clinical outcome and 7-day virological clearance in high-risk patients ' 'with mild-moderate COVID-19 treated with molnupiravir, ' 'nirmatrelvir/ritonavir, or remdesivir. Infect Dis Ther. ' '2024;13(7):1589–605. https://doi.org/10.1007/s40121-024-00994-3.', 'journal-title': 'Infect Dis Ther'}, { 'issue': '7', 'key': '2062_CR22', 'doi-asserted-by': 'publisher', 'first-page': '632', 'DOI': '10.1001/jama.2021.0202', 'volume': '325', 'author': 'RL Gottlieb', 'year': '2021', 'unstructured': 'Gottlieb RL, Nirula A, Chen P, Boscia J, Heller B, Morris J, et al. ' 'Effect of bamlanivimab as monotherapy or in combination with etesevimab ' 'on viral load in patients with mild to moderate COVID-19: a randomized ' 'clinical trial. JAMA. 2021;325(7):632–44. ' 'https://doi.org/10.1001/jama.2021.0202.', 'journal-title': 'JAMA'}, { 'issue': '23', 'key': '2062_CR23', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2108163', 'volume': '385', 'author': 'DM Weinreich', 'year': '2021', 'unstructured': 'Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, et al. ' 'REGEN-COV antibody combination and outcomes in outpatients with ' 'Covid-19. N Engl J Med. 2021;385(23): e81. ' 'https://doi.org/10.1056/NEJMoa2108163.', 'journal-title': 'N Engl J Med'}, { 'issue': '7906', 'key': '2062_CR24', 'doi-asserted-by': 'publisher', 'first-page': '553', 'DOI': '10.1038/s41586-022-04594-4', 'volume': '604', 'author': 'S Iketani', 'year': '2022', 'unstructured': 'Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, et al. Antibody ' 'evasion properties of SARS-CoV-2 Omicron sublineages. Nature. ' '2022;604(7906):553–6. https://doi.org/10.1038/s41586-022-04594-4.', 'journal-title': 'Nature'}, { 'issue': '2', 'key': '2062_CR25', 'doi-asserted-by': 'publisher', 'first-page': '280', 'DOI': '10.1093/cid/ciad181', 'volume': '77', 'author': 'M Mikulska', 'year': '2023', 'unstructured': 'Mikulska M, Sepulcri C, Dentone C, Magne F, Balletto E, Baldi F, et al. ' 'Triple combination therapy with 2 antivirals and monoclonal antibodies ' 'for persistent or relapsed severe acute respiratory syndrome coronavirus ' '2 infection in immunocompromised patients. Clin Infect Dis. ' '2023;77(2):280–6. https://doi.org/10.1093/cid/ciad181.', 'journal-title': 'Clin Infect Dis'}, { 'issue': '6576', 'key': '2062_CR26', 'doi-asserted-by': 'publisher', 'first-page': '43', 'DOI': '10.1126/science.abm3425', 'volume': '375', 'author': 'PB Gilbert', 'year': '2022', 'unstructured': 'Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, et ' 'al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine ' 'efficacy clinical trial. Science. 2022;375(6576):43–50. ' 'https://doi.org/10.1126/science.abm3425.', 'journal-title': 'Science'}, { 'issue': 'Suppl 1', 'key': '2062_CR27', 'doi-asserted-by': 'publisher', 'first-page': 'S4', 'DOI': '10.1093/infdis/jiad181', 'volume': '228', 'author': 'A Antinori', 'year': '2023', 'unstructured': 'Antinori A, Bausch-Jurken M. The burden of COVID-19 in the ' 'immunocompromised patient: implications for vaccination and needs for ' 'the future. J Infect Dis. 2023;228(Suppl 1):S4–12. ' 'https://doi.org/10.1093/infdis/jiad181.', 'journal-title': 'J Infect Dis'}, { 'key': '2062_CR28', 'doi-asserted-by': 'publisher', 'unstructured': 'Update to living WHO guideline on drugs for covid-19. BMJ. ' '2023;383:2622. https://doi.org/10.1136/bmj.p2622.', 'DOI': '10.1136/bmj.p2622'}, { 'issue': '3', 'key': '2062_CR29', 'doi-asserted-by': 'publisher', 'first-page': '280', 'DOI': '10.1093/aje/kwg115', 'volume': '158', 'author': 'MS Cepeda', 'year': '2003', 'unstructured': 'Cepeda MS, Boston R, Farrar JT, Strom BL. Comparison of logistic ' 'regression versus propensity score when the number of events is low and ' 'there are multiple confounders. Am J Epidemiol. 2003;158(3):280–7. ' 'https://doi.org/10.1093/aje/kwg115.', 'journal-title': 'Am J Epidemiol'}, { 'issue': '1', 'key': '2062_CR30', 'doi-asserted-by': 'publisher', 'first-page': '14', 'DOI': '10.1093/ckj/sfab158', 'volume': '15', 'author': 'NC Chesnaye', 'year': '2022', 'unstructured': 'Chesnaye NC, Stel VS, Tripepi G, Dekker FW, Fu EL, Zoccali C, et al. An ' 'introduction to inverse probability of treatment weighting in ' 'observational research. Clin Kidney J. 2022;15(1):14–20. ' 'https://doi.org/10.1093/ckj/sfab158.', 'journal-title': 'Clin Kidney J'}, { 'issue': '4', 'key': '2062_CR31', 'doi-asserted-by': 'publisher', 'first-page': '403', 'DOI': '10.1037/1082-989X.9.4.403', 'volume': '9', 'author': 'DF McCaffrey', 'year': '2004', 'unstructured': 'McCaffrey DF, Ridgeway G, Morral AR. Propensity score estimation with ' 'boosted regression for evaluating causal effects in observational ' 'studies. Psychol Methods. 2004;9(4):403–25. ' 'https://doi.org/10.1037/1082-989X.9.4.403.', 'journal-title': 'Psychol Methods'}, { 'issue': '12', 'key': '2062_CR32', 'doi-asserted-by': 'publisher', 'first-page': '1149', 'DOI': '10.1093/aje/kwj149', 'volume': '163', 'author': 'MA Brookhart', 'year': '2006', 'unstructured': 'Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Sturmer T. ' 'Variable selection for propensity score models. Am J Epidemiol. ' '2006;163(12):1149–56. https://doi.org/10.1093/aje/kwj149.', 'journal-title': 'Am J Epidemiol'}, { 'issue': '4', 'key': '2062_CR33', 'doi-asserted-by': 'publisher', 'first-page': '711', 'DOI': '10.1016/j.jpainsymman.2014.05.014', 'volume': '48', 'author': 'MM Garrido', 'year': '2014', 'unstructured': 'Garrido MM. Propensity scores: a practical method for assessing ' 'treatment effects in pain and symptom management research. J Pain ' 'Symptom Manage. 2014;48(4):711–8. ' 'https://doi.org/10.1016/j.jpainsymman.2014.05.014.', 'journal-title': 'J Pain Symptom Manage'}, { 'issue': '3', 'key': '2062_CR34', 'doi-asserted-by': 'publisher', 'first-page': '877', 'DOI': '10.1007/s15010-023-02125-5', 'volume': '52', 'author': 'HM Orth', 'year': '2024', 'unstructured': 'Orth HM, Flasshove C, Berger M, Hattenhauer T, Biederbick KD, Mispelbaum ' 'R, et al. Early combination therapy of COVID-19 in high-risk patients. ' 'Infection. 2024;52(3):877–89. ' 'https://doi.org/10.1007/s15010-023-02125-5.', 'journal-title': 'Infection'}, { 'key': '2062_CR35', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/cid/ciac724', 'author': 'A Bhimraj', 'year': '2022', 'unstructured': 'Bhimraj A, Morgan RL, Shumaker AH, Baden L, Cheng VCC, Edwards KM, et ' 'al. Infectious diseases society of America Guidelines on the treatment ' 'and management of patients with COVID-19. Clin Infect Dis. 2022. ' 'https://doi.org/10.1093/cid/ciac724.', 'journal-title': 'Clin Infect Dis'}, { 'issue': '1', 'key': '2062_CR36', 'doi-asserted-by': 'publisher', 'first-page': '883', 'DOI': '10.1186/s12879-022-07871-9', 'volume': '22', 'author': 'V Scaglione', 'year': '2022', 'unstructured': 'Scaglione V, Rotundo S, Marascio N, De Marco C, Lionello R, Veneziano C, ' 'et al. Publisher Correction: Lessons learned and implications of early ' 'therapies for coronavirus disease in a territorial service centre in the ' 'Calabria region: a retrospective study. BMC Infect Dis. 2022;22(1):883. ' 'https://doi.org/10.1186/s12879-022-07871-9.', 'journal-title': 'BMC Infect Dis'}, { 'issue': '1', 'key': '2062_CR37', 'doi-asserted-by': 'publisher', 'first-page': '564', 'DOI': '10.1186/s12879-024-09466-y', 'volume': '24', 'author': 'S Rotundo', 'year': '2024', 'unstructured': 'Rotundo S, Berardelli L, Gulli S, La Gamba V, Lionello R, Russo A, et ' 'al. Early initiation of combined therapy in severely immunocompromised ' 'patients with COVID-19: a retrospective cohort study. BMC Infect Dis. ' '2024;24(1):564. https://doi.org/10.1186/s12879-024-09466-y.', 'journal-title': 'BMC Infect Dis'}, { 'key': '2062_CR38', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.lanepe.2023.100747', 'volume': '35', 'author': 'RA Evans', 'year': '2023', 'unstructured': 'Evans RA, Dube S, Lu Y, Yates M, Arnetorp S, Barnes E, et al. Impact of ' 'COVID-19 on immunocompromised populations during the Omicron era: ' 'insights from the observational population-based INFORM study. Lancet ' 'Reg Health Eur. 2023;35: 100747. ' 'https://doi.org/10.1016/j.lanepe.2023.100747.', 'journal-title': 'Lancet Reg Health Eur'}, { 'key': '2062_CR39', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/cid/ciae308', 'author': 'M Boeckh', 'year': '2024', 'unstructured': 'Boeckh M, Pergam SA, Limaye AP, Englund J, Corey L, Hill JA. How ' 'immunocompromised hosts were left behind in the quest to control the ' 'Covid-19 Pandemic. Clin Infect Dis. 2024. ' 'https://doi.org/10.1093/cid/ciae308.', 'journal-title': 'Clin Infect Dis'}, { 'key': '2062_CR40', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S1473-3099(23)00815-0', 'author': 'HM Machkovech', 'year': '2024', 'unstructured': 'Machkovech HM, Hahn AM, Garonzik Wang J, Grubaugh ND, Halfmann PJ, ' 'Johnson MC, et al. Persistent SARS-CoV-2 infection: significance and ' 'implications. Lancet Infect Dis. 2024. ' 'https://doi.org/10.1016/S1473-3099(23)00815-0.', 'journal-title': 'Lancet Infect Dis'}, { 'key': '2062_CR41', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cmi.2024.05.022', 'author': 'SE Meijer', 'year': '2024', 'unstructured': 'Meijer SE, Paran Y, Belkin A, Brosh-Nissimov T. ’Persistent COVID-19 in ' 'immunocompromised patients—Israeli society of infectious diseases ' 'consensus statement on diagnosis and management’—Author’s reply. Clin ' 'Microbiol Infect. 2024. https://doi.org/10.1016/j.cmi.2024.05.022.', 'journal-title': 'Clin Microbiol Infect'}, { 'key': '2062_CR42', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cmi.2024.05.011', 'author': 'AE Maraolo', 'year': '2024', 'unstructured': 'Maraolo AE, Moriello NS, Gentile I. Re: Persistent COVID-19 in ' 'immunocompromised patients—Israeli Society of Infectious Diseases ' 'consensus statement on diagnosis and management by Meijer et al. Clin ' 'Microbiol Infect. 2024. https://doi.org/10.1016/j.cmi.2024.05.011.', 'journal-title': 'Clin Microbiol Infect'}, { 'key': '2062_CR43', 'doi-asserted-by': 'publisher', 'first-page': '55', 'DOI': '10.1016/j.ijid.2023.09.021', 'volume': '137', 'author': 'D Focosi', 'year': '2023', 'unstructured': 'Focosi D, Maggi F, D’Abramo A, Nicastri E, Sullivan DJ. Antiviral ' 'combination therapies for persistent COVID-19 in immunocompromised ' 'patients. Int J Infect Dis. 2023;137:55–9. ' 'https://doi.org/10.1016/j.ijid.2023.09.021.', 'journal-title': 'Int J Infect Dis'}, { 'issue': '2', 'key': '2062_CR44', 'doi-asserted-by': 'publisher', 'first-page': '283', 'DOI': '10.1093/jac/dkaa442', 'volume': '76', 'author': 'J Sundararaj Stanleyraj', 'year': '2021', 'unstructured': 'Sundararaj Stanleyraj J, Sethuraman N, Gupta R, Thiruvoth S, Gupta M, ' 'Ryo A. Treating COVID-19: are we missing out the window of opportunity? ' 'J Antimicrob Chemother. 2021;76(2):283–5. ' 'https://doi.org/10.1093/jac/dkaa442.', 'journal-title': 'J Antimicrob Chemother'}, { 'issue': '1', 'key': '2062_CR45', 'doi-asserted-by': 'publisher', 'first-page': 'e13', 'DOI': '10.1016/S2666-5247(20)30172-5', 'volume': '2', 'author': 'M Cevik', 'year': '2021', 'unstructured': 'Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, ' 'SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, ' 'and infectiousness: a systematic review and meta-analysis. Lancet ' 'Microbe. 2021;2(1):e13–22. ' 'https://doi.org/10.1016/S2666-5247(20)30172-5.', 'journal-title': 'Lancet Microbe'}, { 'issue': '2', 'key': '2062_CR46', 'doi-asserted-by': 'publisher', 'first-page': '217', 'DOI': '10.3390/v16020217', 'volume': '16', 'author': 'D Focosi', 'year': '2024', 'unstructured': 'Focosi D, Casadevall A, Franchini M, Maggi F. Sotrovimab: a review of ' 'its efficacy against SARS-CoV-2 variants. Viruses. 2024;16(2):217. ' 'https://doi.org/10.3390/v16020217.', 'journal-title': 'Viruses'}, { 'issue': '8', 'key': '2062_CR47', 'doi-asserted-by': 'publisher', 'first-page': '1757', 'DOI': '10.3390/v15081757', 'volume': '15', 'author': 'A De Vito', 'year': '2023', 'unstructured': 'De Vito A, Colpani A, Poliseno M, Diella L, Ieva FRP, Belati A, et al. ' 'What is the efficacy of sotrovimab in reducing disease progression and ' 'death in people with COVID-19 during the Omicron Era? Answers from a ' 'real-life study. Viruses. 2023;15(8):1757. ' 'https://doi.org/10.3390/v15081757.', 'journal-title': 'Viruses'}, { 'issue': '51', 'key': '2062_CR48', 'doi-asserted-by': 'publisher', 'first-page': '1357', 'DOI': '10.15585/mmwr.mm7251a1', 'volume': '72', 'author': 'DJ Smith', 'year': '2023', 'unstructured': 'Smith DJ, Lambrou A, Patel P. SARS-CoV-2 rebound with and without use of ' 'COVID-19 oral antivirals. MMWR Morb Mortal Wkly Rep. ' '2023;72(51):1357–64. https://doi.org/10.15585/mmwr.mm7251a1.', 'journal-title': 'MMWR Morb Mortal Wkly Rep'}, { 'issue': '11', 'key': '2062_CR49', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.29228', 'volume': '95', 'author': 'SW Kang', 'year': '2023', 'unstructured': 'Kang SW, Kim JW, Kim JY, Lim SY, Jang CY, Chang E, et al. Virological ' 'characteristics and the rapid antigen test as deisolation criteria in ' 'immunocompromised patients with COVID-19: a prospective cohort study. J ' 'Med Virol. 2023;95(11): e29228. https://doi.org/10.1002/jmv.29228.', 'journal-title': 'J Med Virol'}], 'container-title': 'European Journal of Medical Research', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1186/s40001-024-02062-5.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1186/s40001-024-02062-5/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1186/s40001-024-02062-5.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 10, 4]], 'date-time': '2024-10-04T07:05:19Z', 'timestamp': 1728025519000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-024-02062-5'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 10, 4]]}, 'references-count': 49, 'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2024, 12]]}}, 'alternative-id': ['2062'], 'URL': 'http://dx.doi.org/10.1186/s40001-024-02062-5', 'relation': {}, 'ISSN': ['2047-783X'], 'subject': [], 'container-title-short': 'Eur J Med Res', 'published': {'date-parts': [[2024, 10, 4]]}, 'assertion': [ { 'value': '3 August 2024', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '12 September 2024', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '4 October 2024', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'Study protocol was approved by Local Ethic Committee (n. AOP 0002323, January ' '1rst, 2022). Each patient was requested to sign written informed consent for ' 'participation.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Ethics approval and consent to participate'}}, { 'value': 'M.M. and A.C. received a research grant from Gilead Sciences, speakers’ ' 'honoraria from ViiV Healthcare, Gilead Sciences, and Merck Sharp & Dohme, and ' 'advisory board fees from ViiV Healthcare. V.S. received speakers’ honoraria ' 'from Angelini. All the other authors do not have any conflicts of interest to ' 'disclose. The authors declare no competing interests.', 'order': 3, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Competing interests'}}], 'article-number': '484'}